Scientists test new drug's safety mix with lung meds
NCT ID NCT06070610
Summary
This study aimed to see if taking a new drug candidate (BI 1015550) changes how the body processes two existing medications for lung scarring (nintedanib and pirfenidone). It involved 14 healthy male volunteers. Researchers measured drug levels in the blood to check for safe interaction, which is a standard early step in drug development.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
Conditions
Explore the condition pages connected to this study.